MedPath

INDIVIOR PTY LTD

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

21

TGA:21

Drug Approvals

SUBLOCADE buprenorphine 100 mg/0.5 mL modified release solution for injection pre-filled syringe (with needle) (303476)

Product Name
SUBLOCADE buprenorphine 100 mg/0.5 mL modified release solution for injection pre-filled syringe (with needle)
Approval Date
Jul 18, 2019
TGA

SUBLOCADE buprenorphine 300 mg/1.5 mL modified release solution for injection pre-filled syringe (with needle) (303753)

Product Name
SUBLOCADE buprenorphine 300 mg/1.5 mL modified release solution for injection pre-filled syringe (with needle)
Approval Date
Jul 18, 2019
TGA

SUBOXONE FILM 4/1 buprenorphine (as hydrochloride) 4 mg / naloxone (as hydrochloride dihydrate) 1 mg soluble film sachet (211117)

Product Name
SUBOXONE FILM 4/1 buprenorphine (as hydrochloride) 4 mg/naloxone (as hydrochloride dihydrate) 1 mg soluble film sachet
Approval Date
May 20, 2014
TGA

SUBOXONE FILM 12/3 buprenorphine (as hydrochloride) 12 mg/naloxone (as hydrochloride dihydrate) 3 mg soluble film sachet (211120)

Product Name
SUBOXONE FILM 12/3 buprenorphine (as hydrochloride) 12 mg naloxone (as hydrochloride dihydrate) 3 mg soluble film sachet
Approval Date
May 20, 2014
TGA

SUBOXONE FILM 8/2 buprenorphine (as hydrochloride) 8 mg/naloxone (as hydrochloride dihydrate) 2 mg soluble film sachet (163444)

Product Name
SUBOXONE FILM 8/2 buprenorphine (as hydrochloride) 8 mg/naloxone (as hydrochloride dihydrate) 2 mg soluble film sachet
Approval Date
Feb 18, 2011
TGA

SUBOXONE FILM 2/0.5 buprenorphine (as hydrochloride) 2 mg/naloxone (as hydrochloride dihydrate) 0.5 mg soluble film sachet (163443)

Product Name
SUBOXONE FILM 2/0.5 buprenorphine (as hydrochloride) 2 mg/naloxone (as hydrochloride dihydrate) 0.5 mg soluble film sachet
Approval Date
Feb 18, 2011
TGA

BUPRADEX buprenorphine 0.4mg (as hydrochloride) tablet blister pack (152475)

Product Name
BUPRADEX buprenorphine 0.4mg (as hydrochloride) tablet blister pack
Approval Date
Feb 9, 2009
TGA

BUPRADEX buprenorphine 2mg (as hydrochloride) tablet blister pack (152476)

Product Name
BUPRADEX buprenorphine 2mg (as hydrochloride) tablet blister pack
Approval Date
Feb 9, 2009
TGA

BUPRADEX buprenorphine 8mg (as hydrochloride) tablet blister pack (152477)

Product Name
BUPRADEX buprenorphine 8mg (as hydrochloride) tablet blister pack
Approval Date
Feb 9, 2009
TGA

BUPRADONE 8/2 buprenorphine (as hydrochloride) 8 mg and naloxone (as hydrochloride dihydrate) 2 mg sublingual tablet (152484)

Product Name
BUPRADONE 8/2 buprenorphine (as hydrochloride) 8 mg and naloxone (as hydrochloride dihydrate) 2 mg sublingual tablet
Approval Date
Sep 9, 2008
TGA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.